JP2021516668A5 - - Google Patents
Info
- Publication number
- JP2021516668A5 JP2021516668A5 JP2020542989A JP2020542989A JP2021516668A5 JP 2021516668 A5 JP2021516668 A5 JP 2021516668A5 JP 2020542989 A JP2020542989 A JP 2020542989A JP 2020542989 A JP2020542989 A JP 2020542989A JP 2021516668 A5 JP2021516668 A5 JP 2021516668A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- slamf6
- cells
- cell population
- cell
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862629129P | 2018-02-12 | 2018-02-12 | |
| US62/629,129 | 2018-02-12 | ||
| PCT/IL2019/050163 WO2019155474A1 (en) | 2018-02-12 | 2019-02-11 | Modulation of slamf6 splice variants for cancer therapy |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021516668A JP2021516668A (ja) | 2021-07-08 |
| JPWO2019155474A5 JPWO2019155474A5 (https=) | 2022-02-21 |
| JP2021516668A5 true JP2021516668A5 (https=) | 2022-02-21 |
| JP7458318B2 JP7458318B2 (ja) | 2024-03-29 |
Family
ID=67548888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542989A Active JP7458318B2 (ja) | 2018-02-12 | 2019-02-11 | 癌治療のためのｓｌａｍｆ６スプライスバリアントの調節 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11834487B2 (https=) |
| EP (1) | EP3752252A4 (https=) |
| JP (1) | JP7458318B2 (https=) |
| IL (1) | IL276117B1 (https=) |
| WO (1) | WO2019155474A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL267614A (en) | 2019-06-24 | 2019-09-26 | Lotem Michal | Nucleic acids to modulate SLAMF6 isoforms |
| CN117867107A (zh) * | 2023-11-24 | 2024-04-12 | 南通大学附属医院 | 一种构建肠癌诊断和预后相关的甲基化位点的诊断模型方法及其诊断标志物slamf6 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US7479269B2 (en) | 1988-11-23 | 2009-01-20 | Genetics Institute, Llc | Methods for selectively enriching TH1 and TH2 cells |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5719867A (en) | 1995-06-30 | 1998-02-17 | Scientific-Atlanta, Inc. | Plural telephony channel baseband signal demodulator for a broadband communications system |
| CA2454185A1 (en) | 2001-07-19 | 2003-01-30 | Innate Pharma | Ntb-a, a surface molecule involved in natural killer cells activity |
| MXPA04001986A (es) | 2001-08-29 | 2004-06-07 | Genentech Inc | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. |
| JP2005206478A (ja) | 2004-01-20 | 2005-08-04 | Kirin Brewery Co Ltd | 樹状細胞膜分子−ＩｇＦｃ融合ポリペプチドまたはそれに対する抗体を含む医薬組成物 |
| WO2005124346A1 (en) | 2004-05-17 | 2005-12-29 | The Board Of Trustees Of The University Of Illinois | 4-1bb receptors are expressed on regulatory t-cells |
| PL1642905T3 (pl) | 2004-10-02 | 2009-04-30 | Immatics Biotechnologies Gmbh | Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy |
| EP1871911A2 (en) | 2005-04-07 | 2008-01-02 | Chiron Corporation | Cancer-related genes (prlr) |
| EP1916302A4 (en) | 2005-08-17 | 2009-10-21 | Takara Bio Inc | PROCESS FOR THE PRODUCTION OF LYMPHOCYTES |
| EP1777523A1 (en) | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| US7847067B2 (en) | 2006-08-28 | 2010-12-07 | ARCA Biopharma | Antibodies to NTB-A |
| WO2012129201A1 (en) | 2011-03-22 | 2012-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| CN105431449B (zh) | 2013-04-05 | 2021-08-24 | 港大科桥有限公司 | 新的pd1同种型及其用于加强免疫应答的用途 |
| US10287354B2 (en) | 2013-12-20 | 2019-05-14 | Novartis Ag | Regulatable chimeric antigen receptor |
| CA2935903A1 (en) | 2014-01-09 | 2015-07-16 | Hadasit Medical Research Services And Development Ltd. | Improved cell compositions and methods for cancer therapy |
| DK3317301T3 (da) | 2015-07-29 | 2021-06-28 | Immutep Sas | Kombinationsterapier omfattende antistofmolekyler mod lag-3 |
| WO2017075478A2 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses by use of immune cell gene signatures |
| NL2017267B1 (en) | 2016-07-29 | 2018-02-01 | Aduro Biotech Holdings Europe B V | Anti-pd-1 antibodies |
| US20190262399A1 (en) | 2016-09-07 | 2019-08-29 | The Broad Institute, Inc. | Compositions and methods for evaluating and modulating immune responses |
| IL267614A (en) | 2019-06-24 | 2019-09-26 | Lotem Michal | Nucleic acids to modulate SLAMF6 isoforms |
-
2019
- 2019-02-11 IL IL276117A patent/IL276117B1/en unknown
- 2019-02-11 WO PCT/IL2019/050163 patent/WO2019155474A1/en not_active Ceased
- 2019-02-11 JP JP2020542989A patent/JP7458318B2/ja active Active
- 2019-02-11 EP EP19751265.0A patent/EP3752252A4/en active Pending
- 2019-02-11 US US16/968,967 patent/US11834487B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Samadi et al. | Therapeutic applications of mesenchymal stem cells:: a comprehensive review | |
| Fan et al. | Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord | |
| Golchin et al. | The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review | |
| Chalisserry et al. | Therapeutic potential of dental stem cells | |
| Liu et al. | Concise reviews: Characteristics and potential applications of human dental tissue-derived mesenchymal stem cells | |
| Vawda et al. | Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives | |
| Nomura et al. | Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection | |
| Trotzier et al. | Fat graft retention: adipose tissue, adipose-derived stem cells, and aging | |
| ES2927461T3 (es) | Células madre mesenquimatosas derivadas de tejido perinatal: método de preparación y utilizaciones de las mismas | |
| Das et al. | Adult mesenchymal stem cells and their potency in the cell-based therapy | |
| Gugjoo et al. | Mesenchymal stem cell research in veterinary medicine | |
| Conese et al. | Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases | |
| IL259120A (en) | Her2-targeted antigen chimeric receptors2 | |
| ES2673861T3 (es) | Método novedoso para tratar el daño a la médula espinal utilizando el fragmento de hmgb1 | |
| CN103687946A (zh) | 用于诱导组织再生的肽及其应用 | |
| WO2008036374A2 (en) | Allogeneic stem cell transplants in non-conditioned recipients | |
| CA3139514A1 (en) | Therapeutically active cells and exosomes | |
| WO2006113881A2 (en) | Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood | |
| US20150104470A1 (en) | Immune modulation by peri-lymphatic or intra-lymphatic cell therapy | |
| CN111979187A (zh) | 一种抗人间充质干细胞衰老及增强其干性特征的方法 | |
| AR037038A1 (es) | Una composicion y metodo para alterar la masa corporal magra y las propiedades oseas en un sujeto | |
| JP2021516668A5 (https=) | ||
| CN115843311A (zh) | 高潜能多能干细胞 | |
| JP2026063215A5 (https=) | ||
| US7553661B2 (en) | Stromal antigen-presenting cells and use thereof |